Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and Gut Microbiome in Obesity
NCT04046822Phase 4Unknown
- Sponsor
- University of Naples Federico II
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, sponsored by University of Naples Federico II. Status: unknown.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04046822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046822.